Page last updated: 2024-08-21

vancomycin and quinupristin-dalfopristin

vancomycin has been researched along with quinupristin-dalfopristin in 106 studies

Research

Studies (106)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	57 (53.77)	18.2507
2000's	32 (30.19)	29.6817
2010's	15 (14.15)	24.3611
2020's	2 (1.89)	2.80

Authors

Authors	Studies
Appelbaum, PC; Jacobs, MR; Spangler, SK	1
Nishino, T	1
Chambers, HF	1
Goto, S; Kaneko, Y; Miyazaki, S	1
Verbist, L; Verhaegen, J	1
Drugeon, H; Entenza, JM; Glauser, MP; Moreillon, P	1
Entenza, JM; Glauser, MP; L'Hériteau, F; Lacassin, F; Leport, C; Moreillon, P	1
Kang, SL; Rybak, MJ	2
Carbon, C; Duval, J; Fantin, B; Leclercq, R; Merlé, Y; Saint-Julien, L; Veyrat, C	1
Cooper, B; Freeman, C; Mazens-Sullivan, M; Nightingale, C; Quintiliani, R; Robinson, A	1
Appelbaum, PC; Jacobs, MR; Pankuch, GA	2
Carbon, C; Duval, J; Fantin, B; Leclercq, R; Maziere, B; Ottaviani, M; Pocidalo, JJ; Vallois, JM	1
Collins, LA; Eliopoulos, GM; Ferraro, MJ; Malanoski, GJ; Moellering, RC; Wennersten, CB	1
Berthaud, N; Conard, BJ; Desnottes, JF; Montay, G	1
Millichap, J; Noskin, GA; Peterson, LR; Ristow, TA	1
Herrera-Insúa, I; Jacques-Palaz, K; Murray, BE; Rakita, RM	1
Zervos, M	1
Furness, KM; Holloway, WJ; Johnson, JA; Johnson, RJ; McIntosh, AC; Qaiyumi, S; Schwalbe, RS; Steele-Moore, L	1
Cormican, MG; Johnson, DM; Jones, RN	1
Chow, JW; Donahedian, SM; Zervos, MJ	1
Chow, JW; Davidson, A; Sanford, E; Zervos, MJ	1
Garcia, R; Raad, I	1
Handwerger, S; Mildvan, D; Shonekan, D	1
Bradley, JS; Scheld, WM	1
Mariano, N; Rahal, JJ; Sahgal, VS; Turner, J; Urban, C; Weinbaum, F	1
Noskin, GA; Peterson, LR; Ristow, TA; Warren, JR	1
Dejesus, D; Dever, LL; Johanson, WG; Kaminski, ZC; Masurekar, M; Patel, D; Smith, SM	1
Dever, LL; Handwerger, S	1
Deobaldia, J; Evans, PA; Norden, CW; Rhoads, S; Silber, JL	1
Furlong, WB; Rakowski, TA	1
Bates, J; Chadwick, PR; Johnson, AP; Palepou, MF; Woodford, N	1
Hardin, TC; Harkless, LB; Reyzelman, AM; Van Gils, CC; Vayser, DJ	1
Messick, CR; Pendland, SL	1
Caron, F; Eliopoulos, GM; Farris, MG; Gold, HS; Moellering, RC; Wennersten, CB	1
Tuohy, M; Washington, JA	1
Casewell, MW; Hill, RL; Seyed-Akhavani, M; Smith, CT	1
Maskell, JP; Sefton, AM; Whiley, AC; Williams, JD	1
Fernandes, F; Lorian, V	2
Berthaud, N; Desnottes, JF; Diallo, N; Huet, Y	1
Kramer, DJ; Linden, PK; McDevitt, D; Pasculle, AW	1
Fluit, A; Heinz, HP; Jones, ME; Schmitz, FJ; Verhoef, J	1
Cerwinka, S; Dowzicky, M; Eliopoulos, GM; Farris, MG; Gold, HS; Moellering, RC; Nadler, HL; Schülin, T; Souli, M; Talbot, GH; Wennersten, CB	1
Busciglio, L; Fontanet, H; Gamouras, G; Larkin, J	1
Bompart, F; Dowzicky, M; Feger, C; Nadler, HL; Pease, M; Talbot, G	1
Aeschlimann, JR; Rybak, MJ; Zervos, MJ	1
Matsumura, S; Simor, AE	1
Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR	1
Aeschlimann, JR; Hershberger, E; Moldovan, T; Rybak, MJ	1
Hayashi, M; Higashitsutsumi, M; Igari, J; Inamatsu, T; Inoue, M; Kaku, M; Kanno, H; Kawai, T; Kobayashi, Y; Kohno, S; Kubo, S; Miyazaki, S; Oguri, T; Saito, A; Sakamoto, M; Shiba, K; Shimada, J; Shimizu, Y; Tokue, Y; Tomono, K; Ubukata, K; Ueda, Y; Watanabe, A; Yamaguchi, K	1
Barriere, SL; Dunn, DL; Graham, DR; Kreter, B; Nichols, RL; Rodgers, A; Wilson, SE; Zervos, M	1
Bozdogan, B; Leclercq, R; Lozniewski, A; Weber, M	1
Péchère, JC	1
Louie, L; Louie, M; Matsumura, SO; Simor, AE	1
Anholm, JD; Cheadle, WG; Fabian, TC; Fagon, J; Falcone, RE; Gibert, C; Haas, DW; Lilienthal, F; Paganin, F; Patrick, H; Torres, A	1
Barry, AL; Brown, SD; Fuchs, PC	2
Chin, KG; Mactal-Haaf, C; McPherson, CE	1
Cortés Sanchez, R; García Alberola, A; Gómez Gómez, J; López Fornas, F; Martínez García, F; Pérez Salmeron, J; Roldán Conesa, D; Ruíz Gómez, J; Valdés Chávarri, M	1
Longworth, DL	1
Carr, LE; English, LL; Hayes, JR; Joseph, SW; Wagner, DD	1
Ferber, D	1
Cadrobbi, P; Cattelan, A; Cusinato, R; Gambino, A; Meneghetti, F; Narne, E; Scano, F; Sgarabotto, D; Zignol, M	1
Saxén, H; Vaara, M	1
Bassetti, D; Bassetti, M; Cenderello, G; Di Biagio, A; Melica, G; Rosso, R	1
García-Rodríguez, JA; Gutiérrez Zufiaurre, MN; Muñoz Bellido, JL; Sánchez Hernández, FJ; Segovia Hernández, M; Yagüe Guirao, G	1
Abb, J	1
Chau, F; Fantin, B; Garry, L; Leclercq, R; Lefort, A; Pavie, J; Zarrouk, V	1
Moyenuddin, M; Ohl, CA; Peacock, JE; Williamson, JC	1
Chatzidimitriou, M; Katikaridou, E; Kollaras, P; Koumentaki, E; Metallidis, S; Nikolaidis, P; Tourkantonis, A; Tsona, A	1
Clark, NM; Hershberger, E; Lynch, JP; Zervosc, MJ	1
Athamna, A; Athamna, M; Bast, DJ; Medlej, B; Rubinstein, E	1
Ahearn, DG; Halliman, DG	1
Lundstrom, TS; Sobel, JD	1
El-Azizi, M; Kanchanapoom, T; Khardori, N; Rao, S	1
Cirioni, O; De Fusco, M; Ghiselli, R; Giacometti, A; Licci, A; Mocchegiani, F; Orlando, F; Provinciali, M; Saba, V; Scalise, G; Silvestri, C	1
Heo, ST; Ki, HK; Kiem, S; Ko, KS; Lee, JY; Moon, CS; Oh, WS; Peck, KR; Song, JH	1
Flynn, HW; Harper, T; Miller, D	1
Chambers, HF; Hegde, SS	1
Hur, JA; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ; Wie, SH	1
Batard, E; Caillon, J; Hamel, A; Jacqueline, C; Potel, G	1
Anstead, GM; Lewis, JS; Quinones-Nazario, G	1
Bhateja, P; Bhatnagar, PK; Fatma, T; Khan, S; Mathur, T; Pandya, M; Rattan, A; Singhal, S; Upadhyay, DJ	1
Adochitei, A; Duez, JM; Neuwirth, C; Péchinot, A; Siebor, E; Sixt, N	1
Alexandre, SS; Huang, V; McGowan, JE; Segal, RE; Sinner, SW; Tenover, FC; Weinstein, MP	1
Appelbaum, PC; Beachel, L; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P; Pankuch, GA	1
Nailor, MD; Sobel, JD	1
Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ	1
Cheung, CM; Leuthner, KD; Rybak, MJ; Vidaillac, C	1
Adali, F; Asan, A; Baltalarli, A; Cevahir, N; Kaleli, I; Onem, G; Sacar, M; Sacar, S; Susam, I; Teke, Z; Turgut, H; Yaylali, YT	1
Sancak, B	1
Aslantas, Ö; Demir, C; Erdem, Z; Türkyilmaz, S; Yilmaz, MA	1
Arslan, U; Aydın, F; Bayramoğlu, G; Baysan, BO; Berktaş, M; Cesur, S; Cöplü, N; Demiröz, AP; Esen, B; Gencer, S; Gülay, Z; Hoşoğlu, S; Irmak, H; Karabiber, N; Kılıç, H; Simşek, H; Yalçın, AN	1
Biavasco, F; Donelli, G; Pasquaroli, S; Vignaroli, C; Vuotto, C; Zandri, G	1
Muscedere, J	1
Hsu, AJ; Tamma, PD	1
Gallagher, JC; Patel, R	1
Behl, P; Chander, J; Gupta, V; Sahoo, T; Singla, N	1
Bartolomeu, AR; Brito, CI; Camargo, CH; Cunha, ML; Oliveira, A; Pereira, VC; Pinheiro, L	1
Ahn, JW; Baek, YS; Jeon, J; Song, HJ	1
Chen, Z; Guo, Y; Li, D; Lv, J; Qi, X; Wang, L; Wang, S; Yu, F; Zhang, X	1
Rybak, MJ; Smith, JR; Yim, J	1
Karahan, ZC; Ozmen Capin, BB; Tekeli, A	1
Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Liao, CH; Lin, CY; Liu, CP; Liu, PY; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tsai, HY; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY	1

Reviews

18 review(s) available for vancomycin and quinupristin-dalfopristin

Article	Year
[Recent trend and development of novel antimicrobial agents for MRSA infections]. Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:5 Topics: Daptomycin; Glycopeptides; Humans; Methicillin Resistance; Peptides; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin	1992
Vancomycin-resistant Enterococcus faecium infections in the ICU and quinupristin/dalfopristin. New horizons (Baltimore, Md.), 1996, Volume: 4, Issue:3 Topics: Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Vancomycin; Virginiamycin	1996
The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24 Suppl 2 Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Chloramphenicol; Clindamycin; Female; Fluoroquinolones; Humans; Infant; Infant, Newborn; Lactams; Male; Meningitis, Bacterial; Naphthyridines; Penicillin Resistance; Rifampin; Streptococcal Infections; Streptococcus pneumoniae; Vancomycin; Virginiamycin	1997
Evaluation of in vitro activity of quinupristin/dalfopristin and comparator antimicrobial agents against worldwide clinical trial and other laboratory isolates. The American journal of medicine, 1998, May-29, Volume: 104, Issue:5A Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clinical Trials, Phase III as Topic; Drug Resistance, Multiple; Enterococcus faecium; Gram-Positive Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus epidermidis; Vancomycin; Virginiamycin	1998
Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristin. The Journal of antimicrobial chemotherapy, 1999, Volume: 44 Suppl A Topics: Anti-Bacterial Agents; Bacteremia; Humans; Methicillin Resistance; Staphylococcal Infections; Vancomycin; Virginiamycin	1999
Use of anti-infective agents during lactation: Part 1--Beta-lactam antibiotics, vancomycin, quinupristin-dalfopristin, and linezolid. Journal of human lactation : official journal of International Lactation Consultant Association, 2000, Volume: 16, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactams; Drug Therapy, Combination; Female; Humans; Lactation; Linezolid; Milk, Human; Mothers; Oxazolidinones; Vancomycin; Virginiamycin	2000
Microbial drug resistance and the roles of the new antibiotics. Cleveland Clinic journal of medicine, 2001, Volume: 68, Issue:6 Topics: Acetamides; Anti-Infective Agents; Atovaquone; Aza Compounds; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Moxifloxacin; Naphthoquinones; Oxazolidinones; Proguanil; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Vancomycin Resistance; Virginiamycin	2001
[New antibacterial agents]. Duodecim; laaketieteellinen aikakauskirja, 1999, Volume: 115, Issue:20 Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Daptomycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Oxazolidinones; Protein Synthesis Inhibitors; Vancomycin; Virginiamycin	1999
Gram-positive bacterial resistance. A challenge for the next millennium. Panminerva medica, 2002, Volume: 44, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Linezolid; Oxazolidinones; Staphylococcus aureus; Vancomycin; Virginiamycin	2002
Antimicrobial resistance among gram-positive organisms in the intensive care unit. Current opinion in critical care, 2003, Volume: 9, Issue:5 Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Community-Acquired Infections; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Linezolid; Methicillin Resistance; Oxazolidinones; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Virginiamycin	2003
Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin. Infectious disease clinics of North America, 2004, Volume: 18, Issue:3 Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacterial Infections; Humans; Vancomycin; Virginiamycin	2004
Combating the growing problem of methicillin-resistant Staphylococcus aureus: do the newer antibiotics represent a better alternative to vancomycin? Expert review of anti-infective therapy, 2007, Volume: 5, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin	2007
Treatment of infections caused by resistant Staphylococcus aureus. Methods in molecular biology (Clifton, N.J.), 2007, Volume: 391 Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin Resistance; Minocycline; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin	2007
Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin. Infectious disease clinics of North America, 2009, Volume: 23, Issue:4 Topics: Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Glycopeptides; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Peptides, Cyclic; Teicoplanin; Vancomycin; Virginiamycin	2009
[Staphylococcus aureus and antibiotic resistance]. Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Protein Synthesis Inhibitors; Staphylococcal Infections; Teicoplanin; Tigecycline; Vancomycin; Vancomycin Resistance; Virginiamycin	2011
Optimizing therapy for vancomycin-resistant enterococcal bacteremia in children. Current opinion in infectious diseases, 2014, Volume: 27, Issue:6 Topics: Acetamides; Adolescent; Child; Child, Preschool; Daptomycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Risk Factors; Treatment Outcome; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin	2014
Vancomycin-resistant enterococcal bacteremia pharmacotherapy. The Annals of pharmacotherapy, 2015, Volume: 49, Issue:1 Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin	2015
Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence. Pharmacotherapy, 2017, Volume: 37, Issue:5 Topics: Animals; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Teicoplanin; Vancomycin; Vancomycin Resistance; Virginiamycin	2017

Trials

4 trial(s) available for vancomycin and quinupristin-dalfopristin

Article	Year
Treatment of vancomycin-resistant Enterococcus faecium infections with an investigational streptogramin antibiotic (quinupristin/dalfopristin): a report of fifteen cases. Microbial drug resistance (Larchmont, N.Y.), 1996,Winter, Volume: 2, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Enterococcus faecium; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Vancomycin; Virginiamycin	1996
Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteraemia: comparison with a control cohort. The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Drug Resistance, Microbial; Enterococcus faecium; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Treatment Outcome; Vancomycin; Virginiamycin	1997
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: two randomized, multicentre studies of quinupristin/dalfopristin versus cefazolin, oxacillin or vancomycin. Synercid Skin and Skin Structure Infection Gr The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:2 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Cefazolin; Cephalosporins; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitalization; Humans; Male; Middle Aged; Oxacillin; Penicillins; Skin Diseases, Bacterial; Vancomycin; Virginiamycin	1999
Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group. American journal of respiratory and critical care medicine, 2000, Volume: 161, Issue:3 Pt 1 Topics: Adult; Aged; Anti-Bacterial Agents; Cross Infection; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Prospective Studies; Treatment Outcome; Vancomycin; Virginiamycin	2000

Other Studies

84 other study(ies) available for vancomycin and quinupristin-dalfopristin

Article	Year
Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:4 Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Quinolones; Streptococcus pneumoniae; Vancomycin; Virginiamycin	1992
Studies of RP 59500 in vitro and in a rabbit model of aortic valve endocarditis caused by methicillin-resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1992, Volume: 30 Suppl A Topics: Animals; Aortic Valve; Drug Combinations; Drug Resistance, Microbial; Endocarditis, Bacterial; Heart Valve Diseases; In Vitro Techniques; Methicillin; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin	1992
The in-vitro activity of RP 59500 against gram-positive cocci. The Journal of antimicrobial chemotherapy, 1992, Volume: 30 Suppl A Topics: Amoxicillin; Ciprofloxacin; Erythromycin; Gram-Positive Cocci; In Vitro Techniques; Josamycin; Methicillin Resistance; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1992
Comparative in-vitro activity of RP 59500. The Journal of antimicrobial chemotherapy, 1992, Volume: 30 Suppl A Topics: Bacteria; Ciprofloxacin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Oxacillin; Vancomycin; Virginiamycin	1992
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7 Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Methicillin Resistance; Microbial Sensitivity Tests; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin	1995
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7 Topics: Animals; Conjugation, Genetic; Drug Resistance, Microbial; Endocarditis, Bacterial; Erythromycin; Female; Microbial Sensitivity Tests; Rats; Rats, Wistar; Streptococcal Infections; Streptococcus; Vancomycin; Virginiamycin	1995
Pharmacodynamics of RP 59500 alone and in combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:7 Topics: Blood Coagulation; Drug Therapy, Combination; Fibrin; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thrombosis; Vancomycin; Virginiamycin	1995
Critical influence of resistance to streptogramin B-type antibiotics on activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2 Topics: Animals; Drug Resistance, Microbial; Endocarditis, Bacterial; Female; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin	1995
In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:1 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Depsipeptides; Drug Resistance, Microbial; Enterococcus; Fluoroquinolones; Fusidic Acid; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Novobiocin; Peptides, Cyclic; Quinolones; Teicoplanin; Vancomycin; Virginiamycin	1995
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:9 Topics: Anti-Infective Agents; Ciprofloxacin; Erythromycin; Fluoroquinolones; Kinetics; Microbial Sensitivity Tests; Penicillin G; Quinolones; Streptococcus pneumoniae; Time Factors; Vancomycin; Virginiamycin	1994
In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:3 Topics: Animals; Autoradiography; Culture Media; Drug Synergism; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus sanguis; Vancomycin; Virginiamycin	1994
In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:3 Topics: Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1993
Bactericidal activity and kinetics of RP 59500 in a mouse model of Staphylococcus aureus septicaemia. The Journal of antimicrobial chemotherapy, 1995, Volume: 36, Issue:2 Topics: Animals; Anti-Bacterial Agents; Bacteremia; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Serum Bactericidal Test; Software; Staphylococcal Infections; Vancomycin; Virginiamycin	1995
Selection of Enterococcus faecium strains with stable and unstable resistance to the streptogramin RP 59500 using stepwise in vitro exposure. Diagnostic microbiology and infectious disease, 1996, Volume: 25, Issue:1 Topics: Anti-Bacterial Agents; Culture Media; Drug Resistance, Microbial; Enterococcus faecium; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1996
Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecium; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Neutrophils; Quinolones; Vancomycin; Virginiamycin	1996
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10 Topics: Anti-Bacterial Agents; Enterococcus; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus; Teicoplanin; Vancomycin; Virginiamycin	1996
Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species. Diagnostic microbiology and infectious disease, 1996, Volume: 24, Issue:1 Topics: Anti-Bacterial Agents; Drug Combinations; Drug Resistance, Microbial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Vancomycin; Virginiamycin	1996
Emergence of increased resistance to quinupristin/dalfopristin during therapy for Enterococcus faecium bacteremia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Resistance, Multiple; Echocardiography; Enterococcus faecium; Gram-Positive Bacterial Infections; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1997
Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 24, Issue:1 Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Coronary Artery Bypass; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Endocarditis; Enterococcus faecalis; Gentamicins; Gram-Positive Bacterial Infections; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Penicillins; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Superinfection; Vancomycin; Virginiamycin; Wound Infection	1997
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:12 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin	1996
Comparative in-vitro activities of RP59500 (quinupristin/dalfopristin), CL 329,998, CL 331,002, trovafloxacin, clinafloxacin, teicoplanin and vancomycin against Gram-positive bacteria. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Quinolones; Teicoplanin; Tetracyclines; Vancomycin; Virginiamycin	1997
Quinupristin/dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report. Microbial drug resistance (Larchmont, N.Y.), 1995,Fall, Volume: 1, Issue:3 Topics: Anti-Bacterial Agents; Arteries; Coronary Artery Bypass; Drug Resistance, Microbial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Middle Aged; Postoperative Complications; Vancomycin; Virginiamycin	1995
In vitro activity of RP 59500 (quinupristin/dalfopristin) and ramoplanin against vancomycin-resistant Enterococcus faecium. Microbial drug resistance (Larchmont, N.Y.), 1995,Winter, Volume: 1, Issue:4 Topics: Anti-Bacterial Agents; Colony Count, Microbial; Depsipeptides; Drug Resistance, Microbial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Kinetics; Microbial Sensitivity Tests; Peptides, Cyclic; Phenotype; Vancomycin; Virginiamycin	1995
Persistence of vancomycin-resistant Enterococcus faecium gastrointestinal tract colonization in antibiotic-treated mice. Microbial drug resistance (Larchmont, N.Y.), 1996,Winter, Volume: 2, Issue:4 Topics: Animals; Anti-Bacterial Agents; Biliary Tract; Colony Count, Microbial; Digestive System; Drug Resistance, Microbial; Enterococcus faecium; Feces; Female; Liver; Mice; Vancomycin; Virginiamycin	1996
In vitro susceptibilities of clinical isolates of vancomycin-resistant enterococci. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6 Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin	1997
Therapy with RP 59500 (quinupristin/dalfopristin) for prosthetic valve endocarditis due to enterococci with VanA/VanB resistance patterns. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:1 Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Middle Aged; Prosthesis-Related Infections; Vancomycin; Virginiamycin	1997
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. Lancet (London, England), 1997, Sep-06, Volume: 350, Issue:9079 Topics: Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Microbial; Enterococcus; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1997
Vancomycin-resistant enterococci osteomyelitis in the foot. A case report. Journal of the American Podiatric Medical Association, 1997, Volume: 87, Issue:9 Topics: Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Humans; Male; Osteomyelitis; Tarsal Bones; Vancomycin; Virginiamycin	1997
In vitro activity of chloramphenicol alone and in combination with vancomycin, ampicillin, or RP 59500 (quinupristin/dalfopristin) against vancomycin-resistant enterococci. Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Vancomycin; Virginiamycin	1997
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium. Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12 Topics: Anti-Bacterial Agents; Cell Cycle; Drug Resistance, Microbial; Enterococcus faecium; Erythromycin; Microbial Sensitivity Tests; Time Factors; Vancomycin; Virginiamycin	1997
Antimicrobial susceptibility of viridans group streptococci. Diagnostic microbiology and infectious disease, 1997, Volume: 29, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin	1997
Bactericidal and inhibitory activity of quinupristin/dalfopristin against vancomycin- and gentamicin-resistant Enterococcus faecium. The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Multiple; Enterococcus faecium; Gentamicins; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1997
In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enterococcus; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Time Factors; Vancomycin; Virginiamycin	1997
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp. The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A Topics: Amoxicillin; Anti-Bacterial Agents; Enterococcus; Erythromycin; Humans; Microbial Sensitivity Tests; Teicoplanin; Vancomycin; Virginiamycin	1997
Synergic activity of vancomycin-quinupristin/dalfopristin combination against Enterococcus faecium. The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A Topics: Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1997
Antistaphylococcal activities of quinupristin/dalfopristin in vitro across platelet-fibrin matrices and in experimental endocarditis. The Journal of antimicrobial chemotherapy, 1997, Volume: 39 Suppl A Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Colony Count, Microbial; Endocarditis, Bacterial; Male; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Vancomycin; Virginiamycin	1997
Stability of the MICs of various antibiotics in different clonal populations of methicillin-resistant Staphylococcus aureus. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Fluoroquinolones; Germany; Hospitals; Humans; Longitudinal Studies; Methicillin Resistance; Microbial Sensitivity Tests; Minocycline; Staphylococcus aureus; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin	1998
Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:5 Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Enterococcus faecium; Humans; Microbial Sensitivity Tests; United States; Vancomycin; Virginiamycin	1998
Staphylococcus epidermidis endocarditis treated with RP 59500 (quinapristin/dalfopristin). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:5 Topics: Adult; Anti-Bacterial Agents; Endocarditis, Bacterial; Humans; Male; Methicillin Resistance; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin; Virginiamycin	1998
Effect of quinupristin/dalfopristin alone or in combination with vancomycin on the structure of Enterococcus faecium. Drugs under experimental and clinical research, 1998, Volume: 24, Issue:2 Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Microbial Sensitivity Tests; Microscopy, Electron; Vancomycin; Virginiamycin	1998
Treatment of vancomycin-resistant Enterococcus faecium with RP 59500 (quinupristin-dalfopristin) administered by intermittent or continuous infusion, alone or in combination with doxycycline, in an in vitro pharmacodynamic infection model with simulated e Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:10 Topics: Anti-Bacterial Agents; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Humans; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1998
Postantibiotic effect and postantibiotic sub-MIC effect of quinupristin-dalfopristin against gram-positive and -negative organisms. Antimicrobial agents and chemotherapy, 1998, Volume: 42, Issue:11 Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin; Virginiamycin	1998
Treatment of endocarditis due to vancomycin-resistant Enterococcus faecium with quinupristin/dalfopristin, doxycycline, and rifampin: a synergistic drug combination. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:6 Topics: Aged; Doxycycline; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Male; Rifampin; Vancomycin; Virginiamycin	1998
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:2 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin	1999
Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:3 Topics: Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Drug Therapy, Combination; Fluoroquinolones; Gentamicins; Glycopeptides; Lipoglycopeptides; Microbial Sensitivity Tests; Naphthyridines; Rifampin; Staphylococcus aureus; Sulbactam; Teicoplanin; Time Factors; Vancomycin; Virginiamycin	1999
[Susceptibilities of Enterococcus faecium, PRSP and MRSA to RP59500 and their correlations with those to other drugs]. The Japanese journal of antibiotics, 1999, Volume: 52, Issue:4 Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Enterococcus faecium; Humans; Methicillin Resistance; Penicillin Resistance; Staphylococcus aureus; Streptococcus pneumoniae; Vancomycin; Virginiamycin	1999
Plasmid-mediated coresistance to streptogramins and vancomycin in Enterococcus faecium HM1032. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:8 Topics: Anti-Bacterial Agents; Drug Resistance, Multiple; Enterococcus faecium; Humans; Plasmids; Vancomycin; Virginiamycin	1999
Synergy testing of vancomycin-resistant Enterococcus faecium against quinupristin-dalfopristin in combination with other antimicrobial agents. Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:11 Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Drug Synergism; Enterococcus faecium; Genotype; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Time Factors; Vancomycin; Vancomycin Resistance; Virginiamycin	1999
Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: clindamycin susceptibility as a surrogate indicator. Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:10 Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Microbial; Drug Therapy, Combination; Microbial Sensitivity Tests; Phenotype; Staphylococcus aureus; Time Factors; Vancomycin; Virginiamycin	2000
Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis due to penicillin- and ceftriaxone-resistant Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:5 Topics: Animals; Anti-Infective Agents; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple; Endocarditis, Bacterial; Fluoroquinolones; Humans; Male; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Rabbits; Streptococcus pneumoniae; Vancomycin; Virginiamycin	2001
Implications of multiple antimicrobial-resistant enterococci associated with the poultry environment. Food additives and contaminants, 2001, Volume: 18, Issue:12 Topics: Animals; Drug Resistance, Multiple, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Feces; Food Microbiology; Gentamicins; Penicillins; Poultry; Streptomycin; United States; Vancomycin; Virginiamycin	2001
Antibiotic resistance. Livestock feed ban preserves drugs' power. Science (New York, N.Y.), 2002, Jan-04, Volume: 295, Issue:5552 Topics: Animal Feed; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Chickens; Drug Resistance, Bacterial; Enrofloxacin; Enterococcus; Europe; Feces; Fluoroquinolones; Glycopeptides; Humans; Quinolones; Swine; United States; United States Food and Drug Administration; Vancomycin; Vancomycin Resistance; Virginiamycin	2002
In vitro bactericidal activity of daptomycin against staphylococci. The Journal of antimicrobial chemotherapy, 2002, Volume: 49, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Therapy, Combination; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin	2002
Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases. Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:2 Topics: Abdominal Abscess; Adult; Aged; Anti-Bacterial Agents; Coagulase; Drug Therapy, Combination; Endocarditis; Female; Heart-Assist Devices; Humans; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin	2002
In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus. International journal of antimicrobial agents, 2002, Volume: 20, Issue:1 Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; In Vitro Techniques; Ketolides; Linezolid; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus aureus; Vancomycin; Virginiamycin	2002
In vitro activity of linezolid, quinupristin-dalfopristin, vancomycin, teicoplanin, moxifloxacin and mupirocin against methicillin-resistant Staphylococcus aureus: comparative evaluation by the E test and a broth microdilution method. Diagnostic microbiology and infectious disease, 2002, Volume: 43, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Mupirocin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin	2002
Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B- type antibiotic Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:9 Topics: Animals; Anti-Bacterial Agents; Culture Media; Drug Resistance; Drug Therapy, Combination; Endocarditis, Bacterial; Lincosamides; Macrolides; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Streptogramin B; Time Factors; Vancomycin; Virginiamycin	2002
Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:1 Topics: Aged; Drug Therapy, Combination; Female; Humans; Oxacillin; Penicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin	2003
Comparative in vitro activity of quinupristin/dalfopristin and seven other antimicrobials against methicillin-susceptible and methicillin-resistant nosocomial Staphylococcus aureus bloodstream isolates. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:6 Topics: Anti-Bacterial Agents; Bacteremia; Clindamycin; Cross Infection; Erythromycin; Gentamicins; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Oxacillin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Virginiamycin	2002
In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis. The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Bacillus anthracis; beta-Lactams; Chloramphenicol; Clindamycin; Fluoroquinolones; Linezolid; Macrolides; Microbial Sensitivity Tests; Oxazolidinones; Rifampin; Tetracyclines; Vancomycin; Virginiamycin	2004
Relative susceptibilities to vancomycin and quinupristin-dalfopristin of adhered and planktonic vancomycin-resistant and vancomycin-susceptible coagulase-negative staphylococci. Current microbiology, 2004, Volume: 48, Issue:3 Topics: Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Catheterization; Coagulase; Drug Resistance, Bacterial; Hydrogels; Methicillin Resistance; Microbial Sensitivity Tests; Silicones; Staphylococcus; Vancomycin; Vancomycin Resistance; Virginiamycin	2004
In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Annals of clinical microbiology and antimicrobials, 2005, Jan-07, Volume: 4 Topics: Acetamides; Biofilms; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Vancomycin; Virginiamycin	2005
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:10 Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Catheters, Indwelling; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combination; Linezolid; Male; Oxazolidinones; Plankton; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin; Virginiamycin	2005
Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus. Journal of Korean medical science, 2006, Volume: 21, Issue:2 Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Bacterial; Drug Synergism; Humans; In Vitro Techniques; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Teicoplanin; Vancomycin; Virginiamycin	2006
In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Ophthalmology, 2007, Volume: 114, Issue:5 Topics: Acetamides; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Aqueous Humor; Aza Compounds; Biological Availability; Coagulase; Endophthalmitis; Eye Infections, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Microbiological Techniques; Moxifloxacin; Oxazolidinones; Quinolines; Staphylococcal Infections; Staphylococcus; Vancomycin; Virginiamycin	2007
Comparison of the MicroScan system and the agar dilution assay for Quinupristin/Dalfopristin susceptibility of Enterococcus faecium. Annals of clinical and laboratory science, 2007,Summer, Volume: 37, Issue:3 Topics: Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus faecium; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Reproducibility of Results; Teicoplanin; Vancomycin; Virginiamycin	2007
Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model. International journal of antimicrobial agents, 2008, Volume: 31, Issue:2 Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Disease Models, Animal; Drug Therapy, Combination; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin	2008
Effect of oxazolidinone, RBx 7644 (ranbezolid), on inhibition of staphylococcal adherence to plastic surfaces. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:4 Topics: Acetamides; Anti-Bacterial Agents; Bacterial Adhesion; Biofilms; Dose-Response Relationship, Drug; Furans; Linezolid; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Plastics; Staphylococcus aureus; Staphylococcus epidermidis; Time Factors; Vancomycin; Virginiamycin	2008
In vitro combinations of five intravenous antibiotics with dalfopristin-quinupristin against Staphylococcus aureus in a 3-dimensional model. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:6 Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Fosfomycin; Gentamicins; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus aureus; Tigecycline; Vancomycin; Virginiamycin	2008
Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy. International journal of antimicrobial agents, 2009, Volume: 33, Issue:6 Topics: Acetamides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; Virginiamycin	2009
Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Enterococcus; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Point Mutation; Staphylococcus; Vancomycin; Virginiamycin	2009
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:6 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin	2010
In vitro activity of the new multivalent glycopeptide-cephalosporin antibiotic TD-1792 against vancomycin-nonsusceptible Staphylococcus isolates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Acetamides; Anti-Bacterial Agents; Cephalosporins; Daptomycin; Glycopeptides; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance; Virginiamycin	2010
Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant Staphylococcus aureus. Texas Heart Institute journal, 2010, Volume: 37, Issue:4 Topics: Acetamides; Animals; Anti-Infective Agents; Aortic Valve; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Infusions, Intravenous; Injections, Intravenous; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Rats; Rats, Wistar; Teicoplanin; Time Factors; Vancomycin; Virginiamycin	2010
Isolation and molecular characterization of methicillin-resistant staphylococci from horses, personnel and environmental sites at an equine hospital in Turkey. The Journal of veterinary medical science, 2012, Volume: 74, Issue:12 Topics: Animal Technicians; Animals; Cross Infection; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Genes, MDR; Horse Diseases; Horses; Humans; Methicillin Resistance; Polymerase Chain Reaction; Rifampin; Species Specificity; Staphylococcal Infections; Staphylococcus; Turkey; Vancomycin; Virginiamycin	2012
[Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey]. Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:3 Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Intensive Care Units; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Minocycline; Oxazolidinones; Staphylococcal Infections; Teicoplanin; Tigecycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin	2012
Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms. The Journal of antimicrobial chemotherapy, 2013, Volume: 68, Issue:8 Topics: Anti-Bacterial Agents; Bacterial Load; Biofilms; Cytokinesis; Gene Expression Profiling; Microbial Viability; Staphylococcus aureus; Vancomycin; Virginiamycin	2013
Which antibiotic for hospital acquired pneumonia caused by MRSA? BMJ (Clinical research ed.), 2014, Feb-13, Volume: 348 Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Cross Infection; Daptomycin; Humans; Linezolid; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Minocycline; Oxazolidinones; Pneumonia, Staphylococcal; Tigecycline; Vancomycin; Virginiamycin	2014
Antimicrobial susceptibility pattern of vancomycin resistant enterococci to newer antimicrobial agents. The Indian journal of medical research, 2015, Volume: 141, Issue:4 Topics: Anti-Infective Agents; Daptomycin; Humans; Linezolid; Minocycline; Tigecycline; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci; Virginiamycin	2015
Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years. Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Blood Culture; Brazil; Daptomycin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals, Teaching; Humans; Linezolid; Minocycline; Mutation; Oxacillin; Prevalence; Staphylococcal Infections; Staphylococcus epidermidis; Staphylococcus haemolyticus; Tigecycline; Vancomycin; Virginiamycin	2016
Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea. International journal of dermatology, 2016, Volume: 55, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clindamycin; Dibekacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Fusidic Acid; Gentamicins; Humans; Infant; Infant, Newborn; Ketolides; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Mupirocin; Oxacillin; Republic of Korea; Retrospective Studies; Rifampin; Staphylococcal Skin Infections; Staphylococcus aureus; Teicoplanin; Tetracycline; Vancomycin; Virginiamycin; Young Adult	2016
Characteristic of Enterococcus faecium clinical isolates with quinupristin/dalfopristin resistance in China. BMC microbiology, 2016, 10-21, Volume: 16, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; China; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Genes, Bacterial; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Prevalence; RNA, Ribosomal, 16S; Vancomycin; Virginiamycin	2016
Evaluation of the Presence and Characterization of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Level Resistance Among Bloodstream Isolates of Methicillin-Resistant Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:3 Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genes, Bacterial; Humans; Linezolid; Methicillin; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phylogeny; Rifampin; Staphylococcal Infections; Tetracycline; Turkey; Vancomycin; Vancomycin Resistance; Virginiamycin	2020
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resist International journal of antimicrobial agents, 2021, Volume: 58, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Daptomycin; Drug Resistance, Bacterial; Enterococcus faecium; Epidemiological Monitoring; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Oxazolidinones; Taiwan; Tetracyclines; Tetrazoles; Tigecycline; Vancomycin; Vancomycin-Resistant Enterococci; Virginiamycin	2021